CDC Pauses Release of COVID Vaccine Effectiveness Study

Medically reviewed by Carmen Pope, BPharm. Last updated on April 10, 2026.

via HealthDay

FRIDAY, April 10, 2026 — A health report on COVID-19 vaccines has been delayed after concerns about how the study was conducted.

The report, from the U.S. Centers for Disease Control and Prevention (CDC), found that COVID vaccines reduced emergency room visits and hospital stays last winter.

But release of the report was postponed by Dr. Jay Bhattacharya, who was serving as the agency’s acting director at the time.

A report summary obtained by The New York Times indicated that the study showed that vaccination:

  • Reduced emergency visits by 50%
  • Reduced hospitalizations by 55%
  • “Dr. Bhattacharya expressed concerns about the observational method used in this study to calculate vaccine effectiveness, and the scientific team is working to address these concerns,” Andrew Nixon, a spokesman for the U.S. Department of Health and Human Services (HHS), told The Times in an email.

    He said the review was routine.

    “Dr. Bhattacharya wants to make sure that the paper uses the most appropriate methodology for such a study," Nixon said.

    The findings were slated for publication March 19 in the CDC’s Morbidity and Mortality Weekly Report (MMWR).

    A few experts said the delay is unusual.

    “A political appointee at CDC would be very rarely involved in a review or decision regarding MMWR,” Dr. Debra Houry told The Times. She served as the CDC’s chief medical officer before resigning in August.

    “Previously this would have been reviewed by a career scientist who worked across administrations,” she added.

    Amid ongoing health threats like measles, staffing shortages and Bhattacharaya heading up the National Institutes of Health, this would be even more unusual, Houry said.

    Observational studies are commonly used to measure vaccine effectiveness.

    Bhattacharya has suggested using randomized clinical trials instead, where some participants receive the vaccine and others receive a placebo.

    However, experts say those trials are often expensive and difficult to conduct quickly.

    Sources

  • The New York Times, April 9, 2026
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords